Growing the love for investing
Results 31 - 40 of 12671 : Previous 1 2 3 4 5 6 7 8 9 Next
Which Big Biotech Is the Best Bet?
That might depend on which kind of investor you are.
Hasn't Cell Therapeutics Ever Heard of All-Nighters?
The biotech withdraws its application to delay a test.
Third time's the charm for Amylin's Bydureon.
Kidney cancer drug Inlyta is approved -- now comes the competition.
Has Gilead Sciences Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
How Can VMware Grow in a Saturated Market?
The answer is twofold: expand the market itself, and tack on a bunch of juicy, profitable upsell extras.
These Dow Stocks May Never Grow Again
Even analysts are pessimistic about the prospects for these stocks.
Facebook IPO Expected to Hit NYSE as "FB"
One company unearths some interesting financial nuggets.
This Just In: Upgrades and Downgrades
Benchmark puts Travelzoo in a cage.
2 Biotech Acquisitions in 1 Day! Let's Throw a Party
Amgen and Celgene pull the trigger. Don't drop the keg.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK